{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:12:37Z","timestamp":1789690357154,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["2024-LCYJ-PY-78"],"award-info":[{"award-number":["2024-LCYJ-PY-78"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pdpdt.2025.105282","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:03:13Z","timestamp":1762570993000},"page":"105282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrating novel OCT-based choroidal imaging: A multimodal nomogram for predicting intravenous glucocorticoid response in thyroid-associated ophthalmopathy"],"prefix":"10.1016","volume":"56","author":[{"given":"Yinru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2025.105282_bib0001","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice. Graves' ophthalmopathy","volume":"360","author":"Bartalena","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/joim.13524","article-title":"Current concepts regarding Graves' orbitopathy","volume":"292","author":"Bartalena","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0003","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-13-0611","article-title":"The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor","volume":"170","author":"Vannucchi","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820958335","article-title":"Glucocorticoids in Graves' orbitopathy: mechanisms of action and clinical application","volume":"11","author":"L\u00e4ngericht","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1292519","article-title":"Predictive markers for anti-inflammatory treatment response in thyroid eye disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0008","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4158\/E161376.OR","article-title":"Variables affecting the long-term outcome of graves orbitopathy following high-dose intravenous glucocorticoid pulse therapy in patients not treated with orbital radiotherapy","volume":"22","author":"Leo","year":"2016","journal-title":"Endocr Pr."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0009","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12020-020-02367-5","article-title":"Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues","volume":"70","author":"Hu","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109839","article-title":"Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL","volume":"142","author":"Zhai","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/wrna.1320","article-title":"Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings?","volume":"7","author":"Keller","year":"2016","journal-title":"Wiley. Interdiscip. Rev. RNa"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cen.13855","article-title":"Factors associated with the efficacy of intravenous methylprednisolone in moderate-to-severe and active thyroid-associated ophthalmopathy: A single-centre retrospective study","volume":"90","author":"Hu","year":"2019","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.609895","article-title":"Evidence that baseline levels of low-density lipoproteins cholesterol affect the clinical response of graves' ophthalmopathy to parenteral corticosteroids","volume":"11","author":"Naselli","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0014","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0260","article-title":"The correlation of the neutrophil-lymphocyte ratio to clinical and imaging parameters in patients with thyroid eye disease","volume":"11","author":"Zhang","year":"2022","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12886-024-03308-w","article-title":"Correlation between choroidal vascularity and retrobulbar ocular blood flow changes and thyroid-associated ophthalmopathy activity: a cross-sectional study","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0016","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s40123-023-00696-y","article-title":"Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease","volume":"12","author":"Lee","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-11-0006","article-title":"A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy","volume":"46","author":"Kumar","year":"2011","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0018","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40618-020-01353-y","article-title":"Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy","volume":"44","author":"Nicol\u00ec","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cen.13873","article-title":"Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis","volume":"90","author":"Aung","year":"2019","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2017.0430","article-title":"High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0021","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40618-017-0718-7","article-title":"Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?","volume":"41","author":"Rotondo Dottore","year":"2018","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JOE-14-0456","article-title":"Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK","volume":"223","author":"Yang","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-021-02090-6","article-title":"The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke","volume":"18","author":"Gong","year":"2021","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12872-022-02636-3","article-title":"Lymphocyte-to-monocyte ratio associated with severe post-stenotic aortic dilation in a case-control study","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0026","first-page":"7","article-title":"Can neutrophil\/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism?","volume":"39","author":"Da\u011fdeviren","year":"2020","journal-title":"J. Med. Biochem."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0027","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.autrev.2014.08.019","article-title":"Th17 cells in inflammation and autoimmunity","volume":"13","author":"Singh","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0028","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0029","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07435800.2023.2219734","article-title":"T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated Ophthalmopathy","volume":"48","author":"Li","year":"2023","journal-title":"Endocr. Res."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/105072502753600160","article-title":"Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy","volume":"12","author":"Hiromatsu","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/347965","article-title":"Sustained interleukin-1\u03b2 exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoids","volume":"2015","author":"Escoll","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0032","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.4049\/jimmunol.1601029","article-title":"Cytokine-Induced Glucocorticoid Resistance from Eosinophil Activation: Protein Phosphatase 5 Modulation of Glucocorticoid Receptor Phosphorylation and Signaling","volume":"197","author":"Pazdrak","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2025.104578","article-title":"Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) for assessing thyroid-associated ophthalmopathy activity","volume":"53","author":"Wu","year":"2025","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7453260","article-title":"Immunological Aspects of Graves' Ophthalmopathy","volume":"2019","author":"\u0141acheta","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0035","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00417-009-1144-0","article-title":"Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features","volume":"247","author":"Konuk","year":"2009","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0036","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2018-01626","article-title":"Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232749","article-title":"Th17 Cells, Glucocorticoid Resistance, and Depression","volume":"12","author":"Khantakova","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0038","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1074\/jbc.R117.777318","article-title":"Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance","volume":"292","author":"Newton","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pdpdt.2025.105282_bib0039","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.immuni.2017.07.012","article-title":"Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action","volume":"47","author":"Oh","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.pdpdt.2025.105282_bib0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s12020-024-03943-9","article-title":"A novel nomogram to predict glucocorticoid response in thyroid-associated ophthalmopathy: findings from a pilot study","volume":"86","author":"Ma","year":"2024","journal-title":"Endocrine"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025008130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025008130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:39:37Z","timestamp":1789688377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100025008130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S1572100025008130"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.105282","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating novel OCT-based choroidal imaging: A multimodal nomogram for predicting intravenous glucocorticoid response in thyroid-associated ophthalmopathy","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.105282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105282"}}